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ABSTRACT 
 
Introduction: In modern day society, pressures from the business and academic worlds cause 
people to consistently self-impose sleep restriction in order to meet deadlines.  To maintain a 
level of alertness during these periods, many individuals rely upon caffeinated beverages in order 
to heighten their awareness and repress their drive for sleep.  However, caffeine’s wakefulness 
promoting properties can negatively affect sleep quality during the following night’s sleep, 
resulting in an individual feeling less rested upon awakening.  
 
 This thesis looked at the combined effects of sleep deprivation and caffeine on daytime 
recovery sleep.  The study design mimics staying up all night in order to meet societal demands 
(e.g. tests, deadlines) and thus is directly translatable to common society.  
  
Methods: Thirty drug free males and females ages 18 to 35 participated in this study. Subjects 
completed an in-laboratory study.  Subjects were given an 8 h baseline polysomnographically 
recorded sleep opportunity on the first night.  Following the baseline night, subjects were sleep 
deprived for 28 h.  Ten subjects were assigned to a caffeine group and administered a caffeine 
pill at 23 h awake. A 5 h recovery sleep opportunity followed the sleep deprivation episode. 
Sleep records were visually scored and compared within subjects and between conditions.  
 
Results: Sleep deprivation significantly decreased amounts of stage 2, REM and REM latency 
during recovery sleep in both the caffeine and placebo groups.  Caffeine, in combination with 
sleep deprivation, significantly increased the amount of wakefulness and decreased the amount 
of stage 3/4 sleep when compared to placebo.  These effects were seen when comparing the 
entire sleep episodes as well as when comparing the first 300 minutes of each sleep episode. 
 
Conclusion:  The effect of caffeine attenuates the ability to dissipate the homeostatic build-up of 
sleep pressure that results from extended wakefulness.  This is seen as a significant interaction 
between caffeine and sleep deprivation in the amount of deep sleep present in the recovery sleep 
episode. We also see a significant increase in the percent wakefulness in the caffeine group when 
compared to placebo indicate that caffeine 5 hours prior to daytime recovery sleep disturbs sleep 
even when sleep pressure is high.   The disturbed sleep findings have important implications for 
individuals who use caffeine to promote wakefulness at night.  
 
Support: NIH R01 HL081761 
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BACKGROUND 
 
 There are several models on sleep regulation; the most widely accepted is the two-
process model. According to the two-process model, sleep is regulated by the balance between 
the homeostatic process (process S) and the circadian process (process C) [5,6].  Process S is the 
sleep pressure that builds up during wakefulness and dissipates during sleep [5].  This sleep 
pressure is aided by the clock-like circadian process that oscillates between high and low 
propensities for sleep throughout the 24 hour day [5,6].  Process S is susceptible to modification 
by behavior and exogenous stimuli.  One such stimulus, caffeine, is the most widely used drug in 
the world and a component of one of the most popular beverages in the world; coffee.  In modern 
times, pressure and high expectations in the business and academic worlds often require 
individuals to maintain wakefulness for long periods of time. In order to do so, many turn to 
caffeine to boost their performance and ward off fatigue. Researchers have found that a typical 
adult in western society consumes 200-300 mg of caffeine a day, which is roughly equivalent to 
a 16 oz. cup of Dunkin’ Donuts coffee [11]. Although caffeine can help an individual for a short 
time, this alertness comes at a price. Caffeine has been reported to profoundly impact sleep in 
regards to both quality and quantity, even in individuals that maintain healthy sleep schedules 
[25]. In order to better illustrate this phenomenon, the present study examines the effects of 
caffeine consumption on the quality of sleep following an episode of extended wakefulness.   
 
Two Process Model of Sleep 
 A circadian rhythm is defined as a biological rhythm that cycles with an approximately 
24 hour period [10].  This circadian process is produced endogenously by the suprachiasmatic 
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nucleus (SCN) of the hypothalamus and produces physiological changes that promote sleep. 
Sleep regulation in the brain is influenced by the circadian system.  This system promotes sleep 
when plasma melatonin levels are high, plasma cortisol levels are decreasing and body 
temperature levels are low [10,14].  This cyclic modulation by the SCN is entrained by 
environmental time cues and is independent of previous sleep-wakefulness history.  
 The homeostatic process, unlike the circadian process, is dependent on an individual’s 
prior sleep-wakefulness history; it builds and dissipates in a non-linear fashion during 
wakefulness and sleep respectively [6,10]. This increasing pressure to sleep throughout 
wakefulness is associated with a build-up of adenosine, a nucleoside that is released during 
metabolism of adenosine triphosphate (ATP) and neural activity [2].   
 
Basic Sleep Architecture 
Sleep consists of two alternating states: non-rapid eye movement (NREM) and rapid eye 
movement (REM) sleep [9].  NREM is further subdivided into stages 1-4, with stage 1 
representing the lightest stage of sleep and 4 the deepest.  The lightest stage of sleep, stage 1, is 
typically found during transitions from wake to sleep [28].  During an individual’s initial sleep 
cycle, stage 1 typically lasts for a period of one to seven minutes [9,28].  Stage 1 is followed by 
stage 2, a deeper stage that is present throughout the sleep episode, making up half of the time 
asleep.  Stage 2 is typically present for 10 to 25 minutes during the first cycle until it gives rise to 
slow-wave sleep (SWS), stages 3 and 4.  SWS, the deepest sleep an individual experiences, is 
usually present for 20-40 minutes during the initial sleep cycle and is most prevalent during the 
first half of a sleep episode [9,28]. The final stage of sleep, REM sleep, is interspersed 
throughout the sleep episode.  During the first cycle of sleep, the amount of time spent in REM is 
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relatively brief, lasting one to five minutes [9,28]. Duration in REM then progressively builds 
throughout the night with the longest periods typically in the last third of the sleep episode [28]. 
Sleep is composed of patterned NREM and REM sleep cycles, with each cycle typically 
lasting 90-100 minutes [9,27]. 
Sleep stages are measured and determined through polysomnography (PSG).  PSG is a 
compilation of electrophysiological recordings of brain and muscle activity; consisting of 
electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), and 
electrocardiography (ECG) [28].  PSG is recorded by placing electrodes on the scalp and face of 
a subject to measure the activity in the respective brain areas, muscle activity of the face, and the 
cornea-retinal potential of the eyes.  The PSG record is scored in 30 second intervals, known as 
epochs. Each epoch is scored and categorized into one of the stages of sleep based upon 
patterned characteristics of the recorded traces; signal frequency, amplitude, and morphology.   
Stage 1 of NREM sleep can be identified by waves that are relatively low in amplitude 
and mostly in the theta range. Theta waves fall between 2-7 cycles per second (Hz).  Slow rolling 
eye movements are often present in the EOG recording during this stage as well [28]. 
Stage 2 of NREM sleep is defined by the presence of theta waves, sleep spindles and/or 
K complexes [28].  A sleep spindle is a burst of fast EEG activity in the 12-14 Hz sigma range; a 
K complex is an EEG wave form that consists of a well-formed negative sharp wave followed 
closely by a positive sharp wave with relatively high amplitude.  Both the duration of the K 
complex and sleep spindle should exceed 0.5 seconds [28].  As stage 2 increases in duration 
throughout the beginning of the sleep period, slower delta waves, characterized by 2 Hz or less, 
become more prevalent [6,9,28]. 
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When delta activity is present in 20-50% of an epoch and reaches amplitudes of 75µV or 
greater, the epoch is scored as stage 3 [6,9,28].  Stage 3 is typically present for a few minutes 
before the delta activity becomes prevalent in 50% of the epoch [9]. Once over 50% of the epoch 
consists of delta activity, the epoch is scored as stage 4.  For this thesis, stages 3 and 4 were 
scored together and are referred to as SWS, which is an accepted procedure in reporting SWS.  
REM sleep consists of low voltage, mixed frequency wave forms, which are similar to 
those found in stage 1 sleep. Rapid eye movements in the EOG traces and “sawtooth” waves in 
the EEG traces are common during REM sleep [28].  REM is often preceded and followed by 
either sleep spindles or K complexes, however, during the stage there is an absence of both [28].  
REM is also characterized by low amplitude EMG trace due to muscle atonia [28]. 
Once a sleep episode has been scored, the entire episode can be compiled into a 
hypnogram to describe sleep architecture.  The most common variables assessed are sleep onset 
latency (SOL), total sleep time (TST), sleep efficiency (TST/time in bed), wakefulness after 
sleep onset (WASO),  amount of time spent in the various sleep stages, and the time it takes 
before an individual enters SWS or REM [20].   
 
Sleep Deprivation 
Three common protocols for examining the effects of sleep deprivation on physiological 
variables are: total sleep deprivation (TSD), sleep restriction, and sleep fragmentation [15].  The 
current study employs the TSD protocol and will be the focus of this literature background.  In 
humans, a typical TSD protocol involves a level of sleep deprivation greater than 24 hours [15]. 
The homeostatic regulation of sleep results in a build-up of sleep pressure from one sleep 
episode to the next. Extended periods of wakefulness results in a greater build-up of sleep 
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pressure and can impact sleep architecture [6,15].  Findings from prior studies have shown 
increased SWS, decreased SOL, and decreased percentage of time spent in stage 1 during a 
recovery sleep episode following TSD [6,7,15].   
The increase in slow wave activity (SWA), a marker of sleep pressure, following sleep 
deprivation is thought to be the result of an increase in neuronal inhibition [3,4,6, 22,27].  One 
possible mediator of this change in neural activity could be the activation of inhibitory adenosine 
receptors by the nucleoside adenosine [3,4,22]. 
The presence of slow-wave activity has been hypothesized to be important for the 
consolidation and reconsolidation of memories.  Findings from several studies have 
demonstrated that recollection of words was higher following a period of SWS compared to 
REM or wakefulness [13,16]. 
 
Adenosine 
Adenosine, a component of the energy molecule adenosine triphosphate (ATP), is 
passively and actively released by neurons [22].  Wakefulness has a ~30% greater amount of 
metabolic activity than NREM sleep and thus a higher rate of ATP metabolism [2,22].  This 
increase in metabolism results in an increase in extracellular adenosine, which is then able to 
bind to any of the four adenosine receptor (A1, A2A, A2B, A3) located in the brain [2,22]. When 
adenosine binds to its receptors, it causes an inhibitory effect by hyperpolarizing the cell through 
increased potassium conductance [2].  Hyperpolarizing wake-promoting neurons decreases the 
ability for these neurons to produce action potentials.  This decreased neuron activity is thought 
to result in increased sleep pressure that builds throughout wakefulness [2].  
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Receptor A1 is expressed in the brain cortex, thalamus, hippocampus and basal ganglia; 
findings suggest that it is through this receptor that adenosine impacts sleep [22].  Findings from 
studies in rats have demonstrated that application of a selective A1 agonist results in a dose-
dependent increase in SWA, which suggests that adenosine plays a role in the homeostatic sleep 
process [29]. 
  Receptor A2A, found in the striatum, nucleus accumbens and olfactory bulb, also affects 
sleep.  Methylxanthines, such as caffeine, are competitive antagonists for adenosine and, through 
the blocking of A2A receptors, causes increased alertness [18,22].  Blocking the A2A receptor 
using caffeine has been reported to delay SOL, increase the amount of stage 2, and decrease the 
amount of SWS in subjects with healthy habitual sleep [19,22,23,26].  Research has also 
suggested that caffeine causes increased SOL as well as fragmentation of sleep by increasing 
WASO [2].  Findings using knockout mice suggest that although caffeine also binds to the A1 
receptor, it does not mediate the effect of increased arousal [18]. 
Receptor A2B is thought to be present on the pineal gland, a gland that releases the 
circadian controlled hormone melatonin [17].  It is hypothesized that through this receptor 
caffeine can alter the release of melatonin [31].   
 The locations of A3 receptors vary between species; in human they have been found 
primarily in the lungs and liver [22].  It is believed that this receptor does not directly play a role 
in the mediation of sleep and has greater implications mediating allergic responses [22]. 
 
Previous Studies of Caffeine and Sleep Following Sleep Deprivation 
A study in rats by Wurts and Edgar conducted in 1999 investigated the effects of caffeine 
and sleep deprivation on the expression of NREM and REM sleep.  Ten male rats had four EEG 
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electrodes and two EMG electrodes implanted into their brain.  All rats completed both 
treatments of caffeine and placebo, and thus served as their own control. Baseline data was 
collected over a 48 h period prior to treatment, and then followed by administration of the 
treatment, through injection, and a 6 h sleep deprivation period.  The rats were then allowed a 48 
h recovery opportunity.  Results from this study demonstrated that the caffeine treatment did not 
block the recovery of sleep loss; however, it did slow the rate of recovery in total sleep, NREM 
and REM duration, SWA and sleep continuity [32].   
LaJambe et al. and Carrier et al., looked at the impact of caffeine on recovery sleep in 
humans. In the study conducted by LaJambe et al in 2005, the effects of caffeine in habitually 
low (≤100mg d-1) and high caffeine users (≥400mg d-1) were examined.   Subjects were sleep 
deprived for 27 hours and received doses of 0 mg, 100 mg, or 300 mg of caffeine, three times 
over the 27 hour episode.  Caffeine was administered through chewing gum and dose was kept 
constant for each subject.  The last dose was given 3 hrs before the 8 hr recovery sleep 
opportunity [21].   LaJambe et al. found a significant difference in the TST between the high 
dose and low dose caffeine groups.  Differences in TST between high dose and placebo were 
also found, and were greater, however, the difference was not significant.  Concomitant to the 
reduction of TST, high dose caffeine significantly increased the latency to SWS when compared 
to both placebo and low dose caffeine [21].  In the study by Carrier et al. in 2007 the influence of 
caffeine on nighttime sleep following a typical day of wakefulness and on daytime sleep 
following 25h of sleep deprivation was examined.  Caffeine was administered in 100 mg doses at 
3h and 1h prior to bedtime.  Caffeine increased sleep latency and the percentage of stage 1 sleep, 
and decreased the number of minutes in stage 2 and SWS for both the night and the daytime 
recovery sleep episode.  Furthermore, caffeine decreased TST and REM sleep but only during 
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daytime recovery sleep.  The authors concluded that the greater impact of caffeine during day 
recovery verses nighttime sleep was the combined result of the increased circadian wake 
propensity and dissipation of sleep pressure over the sleep daytime episode.  They also 
concluded that the reduction of SWS, a typical marker of homeostatic sleep drive, by caffeine 
increased the impact of the circadian wake signal.  Like in most caffeine and sleep studies where 
caffeine was administered before nighttime sleep episodes [23,24,25,31,32], caffeine in the 
studies by LaJambe et al. Carrier et al. was administered within 1 to 3 hours prior to the sleep 
episode following sleep deprivation.  Caffeine is more commonly taken during sleep deprivation 
further away from bedtime to promote wakefulness.  The half-life of caffeine is approximately 5-
6 hours [19,25,26] and thus, we tested the influence of caffeine consumption on recovery sleep 
scheduled 5 hours after caffeine administration as administering caffeine 5 h prior to recovery 
sleep is more relevant to real world caffeine use during sleep deprivation.  We hypothesized that 
during the recovery sleep opportunity, following 28 h TSD, both conditions will show increases 
in SWS.  In addition, caffeine is expected to attenuate the increase in SWS caused by extended 
wakefulness.  Caffeine is also expected to increase sleep onset latency and the amount of 
wakefulness during the recovery sleep episode. 
 
METHODS  
Subjects 
 Thirty healthy males and females subjects aged 18-32, 21.6 ± 3.5 (mean±SD), with a 
BMI between 18.5-27, 22.45±2.13(mean±SD) participated in the study.  Subjects were recruited 
through flyers in the community, emails through the university (the Buff Bulletin), website, and 
newspapers advertisements.  Participants were required to have a history free of drug and alcohol 
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dependence, be a non-smoker, and were drug-free (including caffeine and nicotine) for two 
weeks prior to the laboratory session and throughout protocol.  Drug use was determined by self-
report and verified by toxicology at screening and upon inpatient admission. All participants 
gave written informed consent and the institutional human research committee approved the 
procedures for the protocol. Subjects passed a rigorous health screening, conducted in the sleep 
lab and at the clinical translational research center (CTRC) prior to entering the study.   
Screening included medical history, physical exam, electrocardiogram, blood chemistries, and 
psychological tests.  None of the subjects reported regular night work in the preceding 1-year 
period or crossing more than 1 time zone in the previous 3 weeks. Subjects were asked to 
maintain a self-selected sleep schedule of 8 h for 1 week prior to admission to the laboratory.  
The timing of sleep episodes were verified with sleep-wakefulness logs, call-in bed and wake 
times to a time stamped voice-mailbox recorder, and wrist activity and light exposure recordings 
through the use of Actiwatch-L (Mini Mitter, Bend, OR). 
 
Protocol 
This study was part of a larger research protocol examining the phase resetting response 
to bright light and caffeine.  Subjects lived in the Sleep and Chronobiology Laboratory at the 
University of Colorado at Boulder in a special sleep suite that was an environment free from time 
cues for ~3.7 days.  For the in laboratory portion of the protocol, the subjects arrived at the 
laboratory ~5 h before their habitual bedtime.  Upon arrival the subject’s blood pressure, heart 
rate, and temperature were taken and a urine drug test, breathalyzer, and pregnancy test (if 
female) were administered.  Subjects were then given an 8 h baseline sleep opportunity. 
Following the baseline night subjects woke up under a constant routine protocol.  During this 
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protocol, the room temperature was kept stable (22-24º Celsius), the light in the room was kept 
constant at ~1.5 lux, and the subjects were kept in a semi-recumbent seated posture (~30-40 
degrees from horizontal). During this time, the subjects received scheduled meals of known 
caloric value, were asked to complete a number of cognition tests, and were asked to provide 
saliva samples to researchers.  Outside of the scheduled tests, the subjects had free time during 
which they could engage in low-stress activities (read, watch movies, play board games with 
staff, etc.). Continuous electroencephalography (EEG) recordings verified wakefulness. At 23 
hours of wakefulness (5 h before the recovery sleep episode), subjects in the caffeine group were 
administered a caffeine pill (2.9 mg/kg).  At 28 h of wakefulness, subjects were given a 5 h 
recovery sleep opportunity, during which PSG was recorded.  
 
Assessment of EEG Recordings  
Sleep PSG recordings were obtained with Siesta digital sleep recorders (Compumedics 
USA Ltd, Charlotte, NC) using monopolar EEGs referenced to contra-lateral mastoids according 
to the International 10-20 system (C3-A2, C4-A1, O1-A2, F3-A2), right and left EOG, chin 
EMG and electrocardiogram (ECG). Impedences were below 5 kohms. Data were stored and 
sampled at a rate of 256 samples per second per channel with a 12-bit A-D board. High and low 
pass digital filters for EEG and EOG were set at 0.10 and 30 Hz, respectively. High and low pass 
digital filters for EMG were set at 10 and 100 Hz, respectively. Sleep was scored according to 
standard guidelines from brain region C3-A2 [28]. If the C3-A2 trace contained artifact the C4-
A1 trace was used to determine the sleep stage.  Sleep onset latency was defined in two ways: 
SOL3, defined as the time from lights out to the onset of three continuous epochs of EEG 
defined sleep, SOL10, defined as the time from lights out to the onset of 10 continuous minutes, 
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20 epochs, of EEG defined sleep.  Sleep staging was scored according to standard guidelines 
[28]. 
 
Data Analysis 
Each subject had two sleep episodes scored; the first 8 h in duration, the second 5 h in 
duration.  Sleep episodes were scored in 30 second epochs and then analyzed within subjects as 
well as between groups; caffeine, placebo.  Repeated measure ANOVA techniques were used to 
examine the effects of group (placebo, caffeine), sleep episode (baseline, recovery sleep) and the 
interaction between group and sleep episode for SOL (3 and 10), percentages of stage 1, stage 2, 
stage 3/4, REM, and wakefulness.  Additionally, the same sleep measures were analyzed for the 
first 300 min (5 h) of the 8 h baseline sleep episode and compared directly to the 5 h recovery 
sleep episode.  All analyses were performed with STATISTICA, version 6.0 (StatSoft Inc, Tulsa, 
Ok). 
 
RESULTS  
Comparison of Baseline 8h Versus Recovery 5h Sleep Episodes 
ANOVA revealed significant main effects of condition for percentage of stage 3/4 
(p=0.00434) and wakefulness (p=0.00542), and for sleep onset latency 10 (p=0.02774).  
Significant main effects between baseline and recovery sleep episodes were observed for 
percentage of stage 2 (p<0.0001), stage 3/4 (p<0.0001), and REM (p=0.00105), and for sleep 
onset latency to 3 epochs of sleep (p=0.00685) and 10 minutes of sleep (p=0.00218), and REM 
latency (p<0.0001).  Lastly significant interactions between group and sleep episode were 
observed for percentages of stage 1 (p=0.0434), stage 2 (p=0.0364), and stage 3/4 (p=0.0251) 
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sleep with non-significant interaction for the percentage of wakefulness (p=0.0568), and sleep 
onset latency (SOL10 p=0.0921). 
 Table 1 shows sleep measures for baseline and recovery sleep episodes by group. During 
recovery sleep, following 28 h TSD, the placebo group exhibited significant decreases in 
percentages of stage 1, stage 2, REM, as well as decreases in both measures of sleep onset 
latency, and REM latency.  The caffeine group showed significant decreases in percentages of 
stage 2, REM, REM latency, and a non-significant decrease in sleep onset latency to 10 minutes 
of sleep (p=0.0546). Both the placebo and the caffeine groups displayed an increase in 
percentage of slow wave sleep.   
 Between groups there were no differences in baseline sleep measures.  Following sleep 
deprivation and administration of caffeine, the caffeine group had a non-significant increase in 
sleep onset latency (SOL3 p=0.0725), a significantly greater percentage of wakefulness, and a 
significantly lower percentage of slow wave sleep when compared to the placebo group (Table1).  
Measure Placebo Caffeine 
% Recording Time Baseline (8h) Recovery (5h) Baseline (8h) Recovery (5h) 
stage 1  5.0 ± 0.01 3.7±0.00  4.9 ±0.01 5.2 ± 0.01 
stage 2  50.0 ± 0.01 41.5±0.02† 53.7±0.02 37.5±0.03† 
stage 3/4 ª 19.9±0.01 37.1 ± 0.02† 13.7±0.02 25.8±0.03†  
REM  18.8±0.01 14.0±0.01  19.4±0.02 15.1±0.02  
Wakefulness ª 6.3±0.01 3.7±0.03 8.4±0.02 16.5±0.04  
SOL 3(min) 6.1±1.21 2.1±0.61  7.8±1.72 5.5±0.87 
SOL 10 (min) 8.2±2.03 2.1±0.58  12.5±2.87 6.7±0.83 
REML (min) 103.7±8.85 62.7±2.73† 115.9±12.86 59.2±3.97† 
Table 1: Results over full sleep period: denotes p-value = <0.05 from baseline, † denotes p-
value =< 0.001 from baseline, ª denotes significant interaction (p-value<0.01). 
 
Comparison of first 5h of baseline versus 5h of recovery sleep 
Significant main effects of condition during the first 300 min of the sleep episode were 
observer for percentage of stage 3/4 (p=0.0094), wakefulness (p=0.00833), and latency to 10 
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minutes of sleep (p=0.02774).  Between the sleep episodes significant main effects were 
observed for the percentage of stage 2 (p<0.0001), stage 3/4 (p=0.00001), and sleep onset 
latency (SOL 3: p=0.00685, SOL 10: p=0.00218).  During the first 300 min of the sleep episode 
the interaction between group and sleep episode was significant for the percentages of stage 1 
(p=0.0231), stage 2 (p=0.0365), and wakefulness (p=0.0284). 
 Table 2 shows findings for the comparison of the first 300 min of the baseline sleep 
episode with the 300 min of the recovery sleep episode.  The placebo group showed  a significant 
decrease in percentage of stage 2 and a significant increase in percentage of stage 3/4 during the 
recovery versus baseline sleep episode when directly comparing the first 300 min of the sleep 
episodes.  The caffeine group showed a significant decrease in percentage of stage 2  and 
significant increases in percentage of stages 3/4and of wakefulness. 
 Between groups, there was no difference between the first 300 min of the baseline sleep 
periods.  Following sleep deprivation and caffeine administration significantly decreased the 
percentages of stages 3/4 and significantly increased wakefulness compared to placebo. 
Measure Placebo Caffeine 
% Recording Time Baseline (8h) Recovery (5h) Baseline (8h) Recovery (5h) 
stage 1  4.4±0.00 3.7±0.00 4.1±0.01 5.2±0.01 
stage 2  49.9±0.02 41.5±0.02  55.1±0.03 37.5±0.03† 
stage 3/4ª  18.0±0.02 37.1±0.02† 21.1±0.03 25.8±0.03  
REM  12.3±0.01 14.0±0.01 13.2±0.02 15.1±0.02 
Wakefulness ª 5.4±0.01 3.7± 0.03 6.4±0.01 16.5±0.04  
Table 2: Results over first 300 min of sleep period: denotes p-value = <0.05 from baseline, 
† denotes p-value =< 0.001 from baseline, ª denotes significant interaction (p-value<0.01). 
 
DISCUSSION   
 Findings from this study demonstrate that caffeine consumption during sleep deprivation 
negatively affects sleep 5 hours later.   Previously, it has been shown that caffeine administered 
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between 1 to 3 hours prior to daytime recovery sleep increased the latency to sleep[8], the 
latency to SWS[21] and the percentage of stage 1 sleep[8].  Caffeine also decreased the number 
of minutes in stage 2, SWS, TST and REM sleep [8].  Although expected, we did not see a 
significant difference in either of the sleep onset latency measures when comparing between 
caffeine and placebo conditions.    Over the whole sleep episode, the caffeine condition showed a 
significant reduction in the amount of slow wave sleep when compared with the placebo group.  
This is consistent with the theory that slow-wave sleep is the result of adenosine binding to 
receptors. Along with the reduction of slow wave sleep, the caffeine group also displayed an 
increase in the amount of wakefulness, which was expected.  This is consistent with the idea that 
caffeine decreases the depth of sleep. Although we did see an increase in stage 1 in the caffeine 
group, the findings were not significant.  The lack of significance (p= 0.0725) between 
conditions for these measures could be resultant of the small subject population in the caffeine 
treatment group. 
We did see a significant decrease in the sleep latencies between the two sleep episodes 
for both conditions as expected following extended wakefulness. Both conditions also 
demonstrated a decrease in the amount of stage 2 sleep during the daytime recovery sleep 
episode.  This reduction of stage 2 is the result of the increase in the amount of stage 3/4 that is 
seen with an increase in homeostatic sleep pressure.   
  REM latency was decreased during the daytime recovery sleep episodes for both 
conditions.  This finding is consistent with pervious literature as the recovery sleep episode was 
scheduled just after the circadian peak of REM sleep [14].   
   The current findings indicate that the common behavior of using of caffeine during sleep 
deprivation disturbs sleep even when caffeine is taken 5 hours prior to sleep. Future studies 
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should compare effects of other caffeine doses and administration at other times prior to sleep to 
determine if caffeine administered earlier reduces the negative influence on recovery sleep. 
 In summary, the effect of caffeine attenuates the ability to dissipate the homeostatic 
build-up of sleep pressure that results from extended wakefulness.  Caffeine alters the depth of 
sleep and increases the amount of wakefulness during the recovery sleep episode.  This sleep 
disruption likely hinders the restorative property of recovery sleep following sleep deprivation.   
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